Search Within

Samuel Singer

  1. "Sarcoma Service"
Formats
  1. Journal Article (66)
  2. Meeting Abstract (32)
  3. Book Section (2)
Groups
  1. Department of Medicine (100)
  2. GSK Faculty (100)
  3. Sarcoma Service (100)
  4. Sarcoma Surgeons (100)
  5. Solid Tumor Oncology Division (100)
  6. Surgery (100)

More Groups

People
  1. William Tap (80)
  2. Cristina Antonescu (71)
  3. Mark Dickson (51)
  4. Mary Keohan (48)
  5. Ping Chi (47)
  6. Sandra D'Angelo (45)

More People

Years
  1. 2025 (1)
  2. 2024 (13)
  3. 2023 (10)
  4. 2022 (22)
  5. 2021 (5)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (18)
  2. Clinical Cancer Research (14)
  3. Modern Pathology (9)
  4. Annals of Oncology (6)
  5. American Journal of Surgical Pathology (5)
  6. Annals of Surgical Oncology (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (21)
  2. American Association for Cancer Research (16)
  3. Nature Research (9)
  4. Oxford University Press (9)
  5. Nature Publishing Group (8)
  6. Lippincott Williams & Wilkins (7)

More Publishers

Results (100)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcome of 1000 patients with gastrointestinal stromal tumor (GIST) treated by surgery in the pre- and post-imatinib eras
    Journal Article

    Cavnar, M. J.; Seier, K.; Curtin, C.; Balachandran, V. P.; Coit, D. G.; Yoon, S. S.; Crago, A. M.; Strong, V. E.; Tap, W. D.; Gönen, M.; more...
    Annals of Surgery (2021)

    Fulltext@MSK | Save
  • Clinical outcome of leiomyosarcomas with somatic alteration in homologous recombination pathway genes
    Journal Article

    Rosenbaum, E.; Jonsson, P.; Seier, K.; Qin, L. X.; Chi, P.; Dickson, M.; Gounder, M.; Kelly, C.; Keohan, M. L.; Nacev, B.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • A phase II study of MEK162 (binimetinib [BINI]) in combination with imatinib in patients with untreated advanced gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Chi, P.; Qin, L. X.; Kelly, C. M.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Nacev, B.; Crago, A. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Rb and p53-deficient myxofibrosarcoma and undifferentiated pleomorphic sarcoma require Skp2 for survival
    Journal Article

    Li, G. Z.; Okada, T.; Kim, Y. M.; Agaram, N. P.; Sanchez-Vega, F.; Shen, Y.; Tsubokawa, N.; Rios, J.; Martin, A. S.; Dickson, M. A.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets
    Journal Article

    Rosenbaum, E.; Jadeja, B.; Xu, B.; Zhang, L.; Agaram, N. P.; Travis, W.; Singer, S.; Tap, W. D.; Antonescu, C. R.
    Modern Pathology (2020)

    Fulltext@MSK | Save
  • Objective response rate among patients with locally advanced or metastatic sarcoma treated with talimogene laherparepvec in combination with pembrolizumab: A phase 2 clinical trial
    Journal Article

    Kelly, C. M.; Antonescu, C. R.; Bowler, T.; Munhoz, R.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Dholakia, R.; more...
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • A phase II study of epacadostat and pembrolizumab in patients with advanced sarcoma
    Meeting Abstract

    Kelly, C. M.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Qin, L. X.; Adamson, T.; Condy, M. M.; Biniakewitz, M.; Phelan, H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Phase 2 study of the CDK4 inhibitor abemaciclib in dedifferentiated liposarcoma
    Meeting Abstract

    Dickson, M. A.; Koff, A.; D'Angelo, S. P.; Gounder, M. M.; Keohan, M. L.; Kelly, C. M.; Chi, P.; Antonescu, C. R.; Landa, J.; Qin, L. X.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase I study of binimetinib (MEK162) combined with pexidartinib (PLX3397) in patients with advanced gastrointestinal stromal tumor
    Journal Article

    Rosenbaum, E.; Kelly, C.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M.; Keohan, M. L.; Movva, S.; Condy, M.; Adamson, T.; Mcfadyen, C. R.; more...
    The Oncologist (2019)

    Fulltext@MSK | Save
  • A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumor
    Journal Article

    Kelly, C. M.; Shoushtari, A. N.; Qin, L. X.; D’Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Mcfadyen, C.; Sjoberg, A.; Singer, S.; more...
    Investigational New Drugs (2019)

    Fulltext@MSK | Save